Ketamine Investigation into Matthew Perry’s Death Nears Conclusion

LOS ANGELES, California – The investigation surrounding the ketamine supplied to actor Matthew Perry prior to his tragic passing in October is entering its final stages. Sources within law enforcement have indicated that the U.S. Attorney’s Office will soon determine if multiple individuals may face charges in connection to the case.

Authorities are considering the possibility of federal charges, with the option of referring the case back to state prosecutors should federal charges not be pursued. The joint investigation, involving the LAPD, Drug Enforcement Administration, USPS, and the U.S. Attorney’s Office, has been ongoing since Perry’s death.

Perry, best known for his role as Chandler Bing on the beloved sitcom “Friends,” passed away on October 28, 2023, at the age of 54. The autopsy revealed that his death was a result of the acute effects of ketamine. Additional contributing factors listed included drowning, coronary artery disease, and effects of buprenorphine, though these were not the immediate cause of death.

High levels of ketamine in Perry’s blood likely led to him losing consciousness and eventually submerging in water, as indicated by the autopsy findings. The manner of death was ruled as accidental, shedding light on the tragic circumstances surrounding the actor’s untimely passing.

With the investigation drawing to a close and the U.S. Attorney’s Office poised to make crucial decisions, the aftermath of Perry’s death continues to unfold, raising questions about the circumstances that led to the beloved actor’s demise. The collaboration between various law enforcement agencies underscores the complexity of the case and the efforts to bring justice and closure to Perry’s loved ones and fans.